FRAZER, Pa. and MALVERN, Pa., Feb. 23 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that it has exercised its option to acquire Ception ...

Ception's lead product is reslizumab. Reslizumab is a humanized monoclonal antibody (mAb) against interleukin-5 (IL-5) currently in a Phase IIb/III clinical trial for the treatment of pediatric ...

The system targets equipment such as haul trucks, loaders, bulldozers, and excavators, at construction sites, mines, quarries, and industrial plants Equipment such as articulated trucks, haul trucks, ...

If Phase III data on eosinophilic esophagitis drug is positive, Cephalon will pay $250 million to take over Ception. Cephalon will pay $100 million up front for an option to purchase Ception ...

Malvern, Pa.-based Ception Therapeutics, a biotech developing drugs to treat inflammatory disease, raised an additional $14.7 million in its third funding round, bringing the total round to $77 ...

Cephalon and Ception Therapeutics have entered into an agreement that provides Cephalon with an option to purchase all outstanding capital stock of Ception. Ception's lead drug is reslizumab, a ...

What do swimming with a baby and working with heavy machinery have in common? The last thing you want during either activity is an accident. While swim diapers exist for the former, the latter ...

The system targets equipment such as haul trucks, loaders, bulldozers, and excavators, at construction sites, mines, quarries, and industrial plants Jerusalem /PRNewswire/ - Israeli startup Ception ...